|
IL50250A
(en)
|
1975-08-27 |
1980-01-31 |
Hydrophilics Int Inc |
Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups
|
|
US4076942A
(en)
|
1975-10-01 |
1978-02-28 |
Merck & Co., Inc. |
Crystalline dipilocarpinium pamoate
|
|
FR2424930A1
(fr)
|
1978-05-02 |
1979-11-30 |
Inst Khim Drevesiny Akadem |
Nouveaux polymeres d'alcoyl-1(oxo-5 alcoyl-4 tetrahydrofuryl-methyl(3)-5) imidazoles et d'ethers carboxyalcoyliques d'alcool polyvinylique, utiles notamment comme agents m-cholinomimetiques et leur procede de preparation
|
|
HU204047B
(en)
|
1987-01-31 |
1991-11-28 |
Sandoz Ag |
Process for producing pilocarpine derivatives and pharmaceutical compositions comprising such compounds
|
|
US4977176A
(en)
|
1987-01-31 |
1990-12-11 |
Sandoz Ltd. |
Pilocarpine compounds which are used as pharmaceutical agents
|
|
US5080646A
(en)
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
|
JP2771257B2
(ja)
|
1989-06-22 |
1998-07-02 |
岩城製薬株式会社 |
イミダゾール誘導体の製法
|
|
US5322942A
(en)
|
1991-06-03 |
1994-06-21 |
Regents Of The University Of California |
Synthesis of optically active lactones from L-aspartic acid and intermediates thereof
|
|
DE4222459C2
(de)
|
1992-07-08 |
1995-09-14 |
Sigma Tau Ind Farmaceuti |
3,9-disubstituierte-Spiro[5.5]undecane, ein Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten
|
|
US5783701A
(en)
|
1992-09-08 |
1998-07-21 |
Vertex Pharmaceuticals, Incorporated |
Sulfonamide inhibitors of aspartyl protease
|
|
US5723490A
(en)
|
1992-09-08 |
1998-03-03 |
Vertex Pharmaceuticals Incorporated |
THF-containing sulfonamide inhibitors of aspartyl protease
|
|
IS2334B
(is)
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
|
|
DE4334135A1
(de)
|
1993-10-07 |
1995-04-13 |
Merck Patent Gmbh |
Verfahren zur Herstellung von Pilocarpin-Derivaten
|
|
IL113459A
(en)
|
1995-04-23 |
2000-07-16 |
Electromagnetic Bracing System |
Electrophoretic cuff apparatus
|
|
CA2230894A1
(en)
|
1995-09-01 |
1997-03-13 |
Signal Pharmaceuticals, Inc. |
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
|
|
US5811428A
(en)
|
1995-12-18 |
1998-09-22 |
Signal Pharmaceuticals, Inc. |
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
|
|
US6239180B1
(en)
|
1995-11-08 |
2001-05-29 |
The Regents Of The University Of California |
Transdermal therapeutic device and method with capsaicin and capsaicin analogs
|
|
DE69728581D1
(de)
|
1996-01-22 |
2004-05-13 |
Fujisawa Pharmaceutical Co |
Thiazolylbenzofuranderivate und ihre Verwendung als SRS-A- und Leukotrien-Antagonisten
|
|
WO1999021537A1
(fr)
|
1997-10-28 |
1999-05-06 |
Bando Chemical Industries, Ltd. |
Feuille de timbre cutane et procede de production d'une feuille de base pour timbre
|
|
US6329369B1
(en)
|
1997-12-04 |
2001-12-11 |
Allergan Sales, Inc. |
Methods of treating pain and other conditions
|
|
US6103275A
(en)
|
1998-06-10 |
2000-08-15 |
Nitric Oxide Solutions |
Systems and methods for topical treatment with nitric oxide
|
|
DE19827732A1
(de)
|
1998-06-22 |
1999-12-23 |
Rottapharm Bv |
Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
|
|
US6222039B1
(en)
|
1998-07-13 |
2001-04-24 |
Hoffman-La Roche Inc. |
Process for the preparation of chiral lactones
|
|
US6291466B1
(en)
*
|
1998-07-30 |
2001-09-18 |
Allergan Sales, Inc. |
Cholinergic agents in the treatment of presbyopia
|
|
US6312716B1
(en)
|
1999-05-10 |
2001-11-06 |
Peierce Management Llc |
Patch and method for transdermal delivery of bupropion base
|
|
TWI283669B
(en)
|
1999-06-10 |
2007-07-11 |
Allergan Inc |
Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
|
|
US6974588B1
(en)
|
1999-12-07 |
2005-12-13 |
Elan Pharma International Limited |
Transdermal patch for delivering volatile liquid drugs
|
|
WO2002098877A1
(en)
|
2001-06-05 |
2002-12-12 |
Lilly Icos Llc |
Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
|
|
FR2832637B1
(fr)
|
2001-06-07 |
2004-07-30 |
Lefaix Marie Therese Droy |
Utilisation d'un antioxydant pour la fabrication d'un medicament destine au traitement des affections oculaires de surface
|
|
IL166510A0
(en)
|
2002-08-09 |
2006-01-15 |
Nps Pharma Inc |
1,2,4"oxadiazole as modulators of metabotropic glutamate receptor-5
|
|
AU2003272608A1
(en)
|
2002-09-19 |
2004-04-08 |
University Of Utah Research Foundation |
Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson's disease
|
|
GB0309850D0
(en)
|
2003-04-30 |
2003-06-04 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
DE10358539A1
(de)
|
2003-12-15 |
2005-07-07 |
Merck Patent Gmbh |
Carbonsäureamidderivate
|
|
US7767689B2
(en)
|
2004-03-15 |
2010-08-03 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the treatment of cancer
|
|
US8076352B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
|
MXPA06010543A
(es)
|
2004-03-15 |
2007-03-26 |
Ptc Therapeutics Inc |
Derivados de carbolina utiles en la inhibicion de la angiogenesis.
|
|
US8076353B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Inhibition of VEGF translation
|
|
EP1849781A1
(en)
|
2006-04-28 |
2007-10-31 |
Laboratorios del Dr. Esteve S.A. |
Substituted 3-Amino-4-hydroxy pyrrolidines compounds, their preparation and use as medicaments
|
|
CN101522658A
(zh)
|
2006-06-16 |
2009-09-02 |
因迪基恩药物公司 |
作为抗糖尿病药用于控制糖尿病高血糖症和糖尿病并发症的二甲双胍r-(+)硫辛酸盐
|
|
BRPI0714409A2
(pt)
|
2006-07-14 |
2013-03-12 |
Novartis Ag |
derivados de pirimidina como inibidores de alk-5
|
|
GB0724558D0
(en)
*
|
2007-12-15 |
2008-01-30 |
Sharma Anant |
Optical correction
|
|
MX2010007604A
(es)
|
2008-01-11 |
2010-08-02 |
Novartis Ag |
Pirimidinas como inhibidores de cinasa.
|
|
CA2716514A1
(en)
|
2008-02-21 |
2009-08-27 |
Sequoia Pharmaceuticals, Inc. |
Hiv protease inhibitor and cytochrome p450 inhibitor combinations
|
|
US20090326004A1
(en)
|
2008-06-03 |
2009-12-31 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
|
KR20110036044A
(ko)
|
2008-07-18 |
2011-04-06 |
다케다 파머수티컬 컴패니 리미티드 |
벤즈아제핀 유도체들 및 히스타민 ｈ3 길항제로서 이들의 용도
|
|
US20110091459A1
(en)
|
2008-12-11 |
2011-04-21 |
Auspex Pharmaceuticals, Inc. |
Imidazole modulators of muscarinic acetylcholine receptor m3
|
|
WO2010125416A1
(en)
|
2009-04-27 |
2010-11-04 |
Raouf Rekik |
Drug delivery to the anterior and posterior segments of the eye
|
|
PL2470191T3
(pl)
*
|
2009-08-24 |
2014-09-30 |
Stealth Peptides Int Inc |
Sposoby i kompozycje do profilaktyki lub leczenia stanów okulistycznych
|
|
WO2011113060A2
(en)
|
2010-03-12 |
2011-09-15 |
Trana Discovery, Inc. |
Antiviral compounds and methods of use thereof
|
|
GB201007187D0
(en)
|
2010-04-29 |
2010-06-09 |
Iti Scotland Ltd |
Ubiquitination modulators
|
|
SG186085A1
(en)
|
2010-06-03 |
2013-01-30 |
Alnylam Pharmaceuticals Inc |
Biodegradable lipids for the delivery of active agents
|
|
PT2585470T
(pt)
|
2010-06-23 |
2017-03-06 |
Hanmi Science Co Ltd |
Novos derivados fundidos de pirimidina para inibição da actividade da tirosina cinase
|
|
CN102432598A
(zh)
|
2010-09-29 |
2012-05-02 |
江苏恒瑞医药股份有限公司 |
三环化合物、其制备方法及其在医药上的应用
|
|
WO2012065057A2
(en)
|
2010-11-12 |
2012-05-18 |
Exelixis, Inc. |
Phosphatidylinositol 3-kinase inhibitors and methods of their use
|
|
CN103348243A
(zh)
|
2010-11-30 |
2013-10-09 |
基因泰克公司 |
Lrrk2的分析方法和生物标记物
|
|
WO2012079032A2
(en)
|
2010-12-09 |
2012-06-14 |
Trana Discovery, Inc. |
Compositions and methods of treating drug-resistant retroviral infections
|
|
EP2691375B1
(en)
|
2011-03-31 |
2016-03-16 |
Bayer Intellectual Property GmbH |
Substituted benzimidazoles as mps-1 kinase inhibitors
|
|
ES2545135T3
(es)
|
2011-04-06 |
2015-09-08 |
Bayer Pharma Aktiengesellschaft |
Imidazopiridinas sustituidas y compuestos intermedios de las mismas
|
|
JP2012230356A
(ja)
|
2011-04-15 |
2012-11-22 |
Sumitomo Chemical Co Ltd |
化合物、レジスト組成物及びレジストパターンの製造方法
|
|
GB201114448D0
(en)
|
2011-08-22 |
2011-10-05 |
Takeda Pharmaceutical |
Compounds and their use
|
|
US20140228384A1
(en)
|
2011-11-29 |
2014-08-14 |
Genentech, Inc. |
Assays and biomarkers for lrrk2
|
|
GB201122113D0
(en)
|
2011-12-22 |
2012-02-01 |
Convergence Pharmaceuticals |
Novel compounds
|
|
HK1202543A1
(en)
|
2012-01-28 |
2015-10-02 |
Merck Patent Gmbh |
Azaheterocyclic compounds
|
|
WO2013144191A1
(de)
|
2012-03-29 |
2013-10-03 |
Bayer Intellectual Property Gmbh |
Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
|
|
KR101586789B1
(ko)
|
2012-12-28 |
2016-01-19 |
주식회사 종근당 |
양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
|
|
US8853259B2
(en)
*
|
2013-02-07 |
2014-10-07 |
Banavara L. Mylari |
Metformin derivatives for treating diabetes and diabetes complications
|
|
WO2015018754A1
(en)
|
2013-08-08 |
2015-02-12 |
Boehringer Ingelheim International Gmbh |
Novel pyrazine amide compounds
|
|
EP3077003A1
(en)
|
2013-12-03 |
2016-10-12 |
Bayer Pharma Aktiengesellschaft |
Combination of pi3k-inhibitors
|
|
WO2015082376A2
(en)
|
2013-12-03 |
2015-06-11 |
Bayer Pharma Aktiengesellschaft |
Use of pi3k-inhibitors
|
|
US9458156B2
(en)
|
2014-12-23 |
2016-10-04 |
Bristol-Myers Squibb Company |
Tricyclic compounds as anticancer agents
|
|
CA2936146A1
(en)
|
2014-01-06 |
2015-07-09 |
Stealth Biotherapeutics Corp |
Methods and compositions for preventing or treating dominant optic atrophy
|
|
KR20170016987A
(ko)
|
2014-07-01 |
2017-02-14 |
다케다 야쿠힌 고교 가부시키가이샤 |
헤테로시클릭 화합물 및 이들의 레티노이드-관련 희귀 수용체 (ｒｏｒ) 감마-ｔ 저해제로서의 용도
|
|
CN104387364B
(zh)
*
|
2014-12-15 |
2016-11-16 |
南京工业大学 |
L-鸟氨酸硫辛酸复合盐及其制备方法和应用
|
|
EP3522873B1
(en)
|
2016-10-04 |
2022-03-16 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of xerostomia
|